Epigenetics of thyroid cancer and novel therapeutic targets

83Citations
Citations of this article
71Readers
Mendeley users who have this article in their library.

Abstract

An increasing body of evidence suggests that epigenetic changes (DNA methylation, remodeling and post-translational modification of chromatin) play important roles in thyroid tumorigenesis, as a result of their effects on tumor-cell differentiation and proliferation. Epigenetic silencing of various thyroid-specific genes has been detected in thyroid tumors. These changes can diminish the tumor's ability to concentrate radioiodine, which dramatically reduces treatment options. Epigenetic changes in tumor-promoting and tumor-suppressor genes also contribute to the dysregulation of thyrocyte growth and other aspects of tumorigenesis, such as apoptosis, motility and invasiveness. We provide a brief overview of the mechanisms underlying epigenetic regulation of gene expression and the current methods used to investigate it. This is followed by a review of the principal epigenetic alterations detected in thyroid cancer cells, epigenetic strategies for treating thyroid cancers and data from preclinical and clinical studies (some still underway) on the use in this setting of demethylating agents and histone deacetylase inhibitors. © 2011 Society for Endocrinology.

Cite

CITATION STYLE

APA

Russo, D., Damante, G., Puxeddu, E., Durante, C., & Filetti, S. (2011, June). Epigenetics of thyroid cancer and novel therapeutic targets. Journal of Molecular Endocrinology. https://doi.org/10.1530/JME-10-0150

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free